CochLear (OTCMKTS:CHEOY) Cut to Hold at UBS Group

UBS Group cut shares of CochLear (OTCMKTS:CHEOY) from a strong-buy rating to a hold rating in a research report released on Thursday morning,Zacks.com reports.

A number of other research firms have also commented on CHEOY. Zacks Research raised shares of CochLear to a “hold” rating in a research note on Friday, April 17th. Royal Bank Of Canada raised shares of CochLear from a “hold” rating to a “moderate buy” rating in a research note on Monday, January 19th. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy”.

CochLear Price Performance

Shares of OTCMKTS:CHEOY opened at $34.67 on Thursday. CochLear has a 52 week low of $33.56 and a 52 week high of $105.60. The company’s 50 day moving average is $61.43 and its two-hundred day moving average is $80.24.

CochLear Company Profile

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.